Actio Biosciences
Latest round
- Series B
Last raised
- Jun 2025
Total raised
- $102M
Investors
- 6
About Actio Biosciences
Based in California, US, and founded in 2021 by CEO David Goldstein and co-founder John McHutchison, Actio Biosciences, Inc. operates as a research and development company developing genomics and precision medicine for rare and common diseases. In June 2025, Actio Biosciences, Inc. Actio Biosciences, Inc. provides precision medicine for therapeutics that target shared genetics in rare and common diseases. The company offers mutant characterizations services such as functional analysis of pathogenic mutations, disease relevant assays, and direction of modulation. In addition, the firm provides preclinical insights, rare disease trials, and leveraging learnings from monogenic rare diseases. As of 2023, the company specializes in bioinformatics, biology, biotechnology research and chemistry.
Who invested in Actio Biosciences
6 investors across 3 rounds
See all investors in Actio Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Actio Biosciences
Who invested in Actio Biosciences?
Actio Biosciences has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Actio Biosciences raised?
Actio Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Actio Biosciences last raise money?
Actio Biosciences's most recent round on record is a Series B, in Jun 2025.
What does Actio Biosciences do?
Based in California, US, and founded in 2021 by CEO David Goldstein and co-founder John McHutchison, Actio Biosciences, Inc.
Where is Actio Biosciences headquartered?
Actio Biosciences is headquartered in San Diego, US.
Which VCs invest in companies like Actio Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Actio Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Actio Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.